COMPOSITIONS AND METHODS FOR TREATMENT OF NEUROLOGICAL DISORDERS Application WO-2023150552-A1 World Intellectual Property Organisation (WIPO) 10 Aug 2023
THERAPEUTIC AGENTS, PHARMACEUTICAL COMPOSITIONS, AND ASSOCIATED BIOMARKERS BASED ON TRK-B Application WO-2021201710-A1 World Intellectual Property Organisation (WIPO) 07 Oct 2021
USES OF TAU PHOSPHOSITES AS BIOMARKERS FOR ALZHEIMER'S DISEASE Application WO-2021202777-A1 World Intellectual Property Organisation (WIPO) 07 Oct 2021
Protein-based therapy and diagnosis of tau-mediated pathology in alzheimer's disease Grant US-11098106-B2 United States of America 24 Aug 2021
MODULATORS OF C1Q, IN PARTICULAR OF THE INTERACTION OF APOE WITH C1Q, AND USES OF THE… Application WO-2019137922-A1 World Intellectual Property Organisation (WIPO) 18 Jul 2019
Protein-based therapy and diagnosis of tau-mediated pathology in Alzheimer's disease Grant US-9845352-B2 United States of America 19 Dec 2017
Protein-based therapy and diagnosis of tau-mediated pathology in Alzheimer's disease Grant US-9828421-B2 United States of America 28 Nov 2017
Antibody based reagents that specifically recognize toxic oligomeric forms of tau Grant US-9650436-B2 United States of America 16 May 2017
Protein-based therapy and diagnosis of tau-mediated pathology in alzheimer's disease Grant US-9518101-B2 United States of America 13 Dec 2016
Transgenic animal expressing alzheimer's tau protein Grant US-8288608-B2 United States of America 16 Oct 2012